March is National Colorectal Cancer Awareness Month—an excellent time to share info about getting screened for the disease. Before the COVID-19 pandemic, one in 17 Americans were at risk of developing colorectal cancer, with 90 percent of new cases occurring in people 50 and older.
A recent study predicts an 11.9 percent increase in colorectal cancer mortality worldwide because of COVID-19-related delays in screening.
The screening numbers are down, but colorectal cancer has not gone away. The importance of screening is stronger no more than ever.
The five-year survival rate for stage 3 colorectal cancer patients is around 75 percent, up from 50 percent just 15 years ago. According to the American Cancer Society, an estimated 151,030 people will be diagnosed this year. If caught before it spreads to other parts of the body, the five-year survival rate increases to 90 percent.
Read more to get critical info about colorectal cancer screening from the experts at Cancer Treatment Centers of America.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA) is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment.
Stay up to date on all things CTCA! Be sure to follow them on Facebook, Instagram, Twitter, Pinterest and YouTube or call the VIP Line at 800.227.3207 for more information.